Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome

NCT ID: NCT00920179

Last Updated: 2009-06-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Traditional methodological clinical and instrumental diagnostics of the lacrimal gland for the study of glandular architecture and functions are limited and include analysis of tear constituents, evaluation of apparent diffusion coefficients in magnetic resonance imaging and histopathological evaluation of lacrimal gland biopsy specimens. Confocal microscopy is a new emerging technology which is useful as a supplementary diagnostic tool for in vivo assessment of anterior-segment disorders.The use of in vivo confocal microscopy in a comparative study of the microscopic morphology of the salivary/lacrimal glands have not been reported up to date. In this study, we employ laser scanning confocal microscopy to evaluate the morphological changes of the salivary/lacrimal glands in patients with primary Sjögren's syndrome and compare the results with those of healthy control subjects.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Sjogren's Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dry eye group

Dry eye patients with Primary Sjogren's syndrome

No interventions assigned to this group

Controls

Healthy subjects without dry eyes

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The Sjögren's syndrome diagnosis was made according to the revised American-European consensus criteria.
* Briefly, the patients had to have ocular and oral symptoms of dryness,
* clinically diagnosed dry eye and dry mouth disease,
* serum rheumatoid factor and antinuclear antibody levels ≥1:160,
* positive serology for anti SS-A or anti SS-B antibodies,
* labial salivary gland inflammatory infiltration focus score ≥2 and consents for lacrimal gland biopsy to be included into this study.

Exclusion Criteria

* Patients with any history of ocular surgery including punctal occlusion,
* other ocular or systemic disease
* or a history of topical/ systemic drug use or contact lens wear or
* other systemic disorders that would cause dry eyes or that would alter the ocular surface.
Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Keio University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

J&J Ocular Surface and Visual Optics Department

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kazuo Tsubota, Professor

Role: STUDY_DIRECTOR

Keio University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Keio University School of Medicine

Tokyo, , Japan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Japan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

21071965

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome
NCT07185139 NOT_YET_RECRUITING EARLY_PHASE1